Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia.
Ontology highlight
ABSTRACT: Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV-specific neutralizing antibodies were detected for 6 years postinfection.
SUBMITTER: Alshukairi AN
PROVIDER: S-EPMC8084512 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA